SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-004659
Filing Date
2017-03-16
Accepted
2017-03-16 17:22:00
Documents
46
Period of Report
2017-01-31

Document Format Files

Seq Description Document Type Size
1 10-Q kalv-10q_20170131.htm 10-Q 1508099
2 EX-10.1 kalv-ex101_523.htm EX-10.1 119966
3 EX-10.2 kalv-ex102_524.htm EX-10.2 117992
4 EX-31.1 kalv-ex311_8.htm EX-31.1 11735
5 EX-31.2 kalv-ex312_7.htm EX-31.2 10930
6 EX-32.1 kalv-ex321_6.htm EX-32.1 9478
  Complete submission text file 0001564590-17-004659.txt   3896737

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT kalv-20170131.xml EX-101.INS 516764
8 XBRL TAXONOMY EXTENSION SCHEMA kalv-20170131.xsd EX-101.SCH 30438
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kalv-20170131_cal.xml EX-101.CAL 30026
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kalv-20170131_def.xml EX-101.DEF 92627
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE kalv-20170131_lab.xml EX-101.LAB 211112
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kalv-20170131_pre.xml EX-101.PRE 160386
Mailing Address ONE KENDALL SQUARE BUILDING 200, STE. 2203 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 200, STE. 2203 CAMBRIDGE MA 02139 (857) 999-0075
KalVista Pharmaceuticals, Inc. (Filer) CIK: 0001348911 (see all company filings)

IRS No.: 200915291 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 001-36830 | Film No.: 17695553
SIC: 2834 Pharmaceutical Preparations